Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of targeting APRIL.
The post Q&A: Targeting APRIL in IgA Nephropathy Shows Promise first appeared on Physician’s Weekly.
We bring you the best Premium WordPress Themes that perfect for news, magazine, personal blog, etc. Check our landing page for details.